MENA 2024 Recordings-Obesity and the Brain- Supporting the Need for Pharmacologic Treatments

Obesity and the Brain- Supporting the Need for Pharmacologic Treatments

Video Transcription

Video Summary

The speaker, an endocrinologist with expertise in the cardiometabolic field and obesity research, emphasizes the importance of recognizing obesity as a disease. This recognition is crucial for providing fair treatment and overcoming stigma. Obesity is linked to complex factors like genetic predisposition, hormonal imbalances, and brain mechanisms affecting appetite and energy regulation. The speaker highlights the role of brain activity in obesity, noting differences between individuals prone and resistant to the condition, and how these differences are not only functional but also structural.<br /><br />The speaker advocates for treating obesity as a chronic disease, similar to diabetes or hypertension, arguing for the use of long-term pharmacotherapy alongside lifestyle changes. Current and emerging medications can alter the neurobiology associated with obesity, aiding in sustained weight loss and improved health outcomes. The speaker's work includes brain imaging studies showcasing that interventions, like behavioral changes or medication, can modify brain responses and potentially mitigate the effects of obesity. Ultimately, the speaker calls for a shift in narrative and treatment strategies to address obesity effectively and support patients in managing this chronic disease.

Asset Subtitle

Dr. Marc-André Cornier

Keywords

obesity

chronic disease

cardiometabolic

brain mechanisms

pharmacotherapy

genetic predisposition

stigma